Aspen Pharmacare Holdings Ltd (APN) — Cash Flow Reinvestment Rate
Aspen Pharmacare Holdings Ltd (APN) has a Cash Flow Reinvestment Rate of 0.41x as of June 2025, reinvesting ZAC1.38 Billion (capex ZAC1.38 Billion ) from operating cash flow of ZAC3.35 Billion. Check APN cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aspen Pharmacare Holdings Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Aspen Pharmacare Holdings Ltd across 23 annual periods. Explore APN long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Aspen Pharmacare Holdings Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Aspen Pharmacare Holdings Ltd. For live market cap and broader valuation context, see market cap of Aspen Pharmacare Holdings Ltd.
| Year | Reinvestment Rate | Total Reinvested (ZAC) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.99x | ZAC10.27 Billion | ZAC5.16 Billion | ZAC5.05 Billion | ▼ -17.4% |
| 2024 | 2.41x | ZAC15.00 Billion | ZAC6.22 Billion | ZAC5.54 Billion | ▲ +101.5% |
| 2023 | 1.20x | ZAC6.60 Billion | ZAC5.52 Billion | ZAC3.18 Billion | ▲ +32.3% |
| 2022 | 0.90x | ZAC4.86 Billion | ZAC5.37 Billion | ZAC2.70 Billion | ▼ -53.2% |
| 2021 | 1.93x | ZAC13.19 Billion | ZAC6.83 Billion | ZAC3.43 Billion | ▲ +270.1% |
| 2020 | 0.52x | ZAC4.31 Billion | ZAC8.26 Billion | ZAC2.69 Billion | ▼ -54.0% |
| 2019 | 1.14x | ZAC6.82 Billion | ZAC6.00 Billion | ZAC3.58 Billion | ▼ -62.1% |
| 2018 | 3.00x | ZAC21.04 Billion | ZAC7.02 Billion | ZAC8.23 Billion | ▲ +634.9% |
| 2017 | 0.41x | ZAC2.65 Billion | ZAC6.50 Billion | ZAC2.60 Billion | ▼ -66.5% |
| 2016 | 1.22x | ZAC3.90 Billion | ZAC3.20 Billion | ZAC2.80 Billion | ▲ +125.3% |
| 2015 | 0.54x | ZAC2.62 Billion | ZAC4.84 Billion | ZAC2.42 Billion | ▼ -6.9% |
| 2014 | 0.58x | ZAC2.23 Billion | ZAC3.84 Billion | ZAC2.03 Billion | ▼ -46.4% |
| 2013 | 1.08x | ZAC4.32 Billion | ZAC3.99 Billion | ZAC4.32 Billion | ▲ +20.4% |
| 2012 | 0.90x | ZAC2.62 Billion | ZAC2.91 Billion | ZAC2.62 Billion | ▲ +162.1% |
| 2011 | 0.34x | ZAC840.20 Million | ZAC2.45 Billion | ZAC840.20 Million | ▼ -46.0% |
| 2010 | 0.64x | ZAC1.29 Billion | ZAC2.03 Billion | ZAC1.29 Billion | ▼ -79.0% |
| 2009 | 3.02x | ZAC3.91 Billion | ZAC1.29 Billion | ZAC3.91 Billion | ▲ +261.7% |
| 2008 | 0.84x | ZAC545.32 Million | ZAC652.38 Million | ZAC545.32 Million | ▲ +37.1% |
| 2007 | 0.61x | ZAC431.95 Million | ZAC708.56 Million | ZAC431.95 Million | ▼ -20.1% |
| 2006 | 0.76x | ZAC307.02 Million | ZAC402.21 Million | ZAC307.02 Million | ▲ +191.2% |
| 2005 | 0.26x | ZAC167.26 Million | ZAC638.20 Million | ZAC167.26 Million | ▼ -45.0% |
| 2004 | 0.48x | ZAC237.75 Million | ZAC498.74 Million | ZAC237.75 Million | ▼ -29.6% |
| 2003 | 0.68x | ZAC261.27 Million | ZAC385.95 Million | ZAC261.27 Million | — |